Dose Escalation Study With Bispecific Antibodies in Adult Patients With Lupus Nephritis

NCT06975787 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis (LN)

Interventions

DRUG: Vonsetamig
DRUG: Odronextamab

Sponsor

Regeneron Pharmaceuticals